Results 131 to 140 of about 13,707 (310)

Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆ [PDF]

open access: bronze, 2004
Jennifer K. Garrett   +9 more
openalex   +1 more source

Clinical usefulness of mepolizumab in severe eosinophilic asthma

open access: yesTherapeutics and Clinical Risk Management, 2016
Asthma is a chronic inflammatory disorder of the airways with variable clinical severity from very mild and occasional symptoms to recurrent critical exacerbations, at risk of fatal or near-fatal outcome, in a small percentage of patients. Within the different inflammatory cascades involved in asthma, eosinophils play a central role in the pathogenesis
Nicola Facciolongo   +5 more
openaire   +5 more sources

Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study)

open access: yesJournal of Asthma and Allergy, 2023
Stephanie Korn,1 Katrin Milger,2 Dirk Skowasch,3 Christian Schulz,4 Cordula Mohrlang,5 Martin Wernitz,5 Thomas Paulsson,6 Michael Hennig,5 Roland Buhl7 1IKF Pneumologie Mainz, Mainz and Thoraxklinik Heidelberg, Heidelberg, Germany; 2Department of ...
Korn S   +8 more
doaj  

Mepolizumab for the Treatment of Eosinophilic Cystitis: Reply

open access: yesJournal of Investigational Allergology and Clinical Immunology
International ...
Trefond, Ludovic, Kahn, Je
openaire   +3 more sources

Esofagite Eosinofílica [PDF]

open access: yes, 2009
A esofagite eosinofílica constitui uma doença infl amatória do esófago, mundialmente emergente, caracterizada pela infiltração significativa e isolada da mucosa esofágica por eosinófilos.
Gaspar, A, Piedade, S
core  

Mepolizumab, a Humanized Monoclonal Antibody to IL-5, for Severe Eosinophilic Esophagitis in Adults: A Randomized, Placebo-Controlled Double-Blind Trial [PDF]

open access: bronze, 2007
Alex Straumann   +8 more
openalex   +1 more source

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma

open access: yesJournal of Asthma and Allergy, 2020
Jared Silver,1 Michael Bogart,1 Elizabeth Packnett,2 Juan Wu,2 Donna McMorrow,2 Beth Hahn1 1US Medical Affairs, GSK, Research Triangle Park, NC, USA; 2Life Sciences, IBM Watson Health, Bethesda, MD, USACorrespondence: Beth Hahn Email beth.a.hahn@gsk ...
Silver J   +5 more
doaj  

Monitoring mepolizumab treatment in chronic rhinosinusitis with nasal polyps (CRSwNP): Discontinue, change, continue therapy?

open access: yesAllergologie select
Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifactorial inflammatory disease of the mucous membranes of the nose and sinuses. Eosinophilic inflammation is described as a common endotype.
Ludger Klimek   +35 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy